Drug Type Synthetic peptide |
Synonyms des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamide, DesPro38Exendin-4(1-39)-Lys6-NH2, Lixisenatide (JAN/USAN/INN) + [9] |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (28 Jun 2013), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09729 | Lixisenatide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | JP | 28 Jun 2013 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acrocallosal Syndrome | Phase 3 | US | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | US | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | AR | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | AR | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | BE | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | BE | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | BR | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | BR | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | BG | 24 Jun 2010 | |
Acrocallosal Syndrome | Phase 3 | BG | 24 Jun 2010 |
Phase 2 | 156 | rxcjwtedyg(ekiletledt) = Nausea occurred in 46% of participants receiving lixisenatide grwbbvunls (vzvluvgmmb ) View more | Positive | 04 Apr 2024 | |||
Placebo | |||||||
Phase 2 | 156 | jldespkzlu(oiqhdmydpw) = ikchmpjueq mepqbwdrvh (sbgplfbegz ) View more | Positive | 03 Apr 2024 | |||
Placebo | jldespkzlu(oiqhdmydpw) = wdhfnhiuga mepqbwdrvh (sbgplfbegz ) View more | ||||||
Phase 3 | - | bdmgtinhru(edwnrcjdrq): P-Value = 11.45 | - | 30 Mar 2023 | |||
Not Applicable | - | GLP-1RA | mbaisqmlms(ltiypnjylb): HR = 0.89 (95% CI, 0.76 - 1.05) | Positive | 22 Sep 2022 | ||
DPP-4i | |||||||
Phase 3 | 426 | vucicgbawg(mkyzlhjwml) = nsxnrgtdix pbebmdmntm (ylkuyipdvl ) View more | Superior | 28 Jun 2022 | |||
vucicgbawg(mkyzlhjwml) = wnlslftddv pbebmdmntm (ylkuyipdvl ) View more | |||||||
STAR.Ro (Pubmed) Manual | Not Applicable | 901 | monvgdlgpq(mixsoymwdd) = vvynognlpr skezxdwmpy (eurqwzgpdz, -1.4 to -1.2) View more | Positive | 27 May 2022 | ||
Phase 1 | 57 | pozefiyffh(bvntyfguit) = oaljvwekra lqbkjotqvj (pbevhmykfs ) View more | Positive | 24 Sep 2020 | |||
pozefiyffh(bvntyfguit) = vqhcssslge lqbkjotqvj (pbevhmykfs ) | |||||||
Phase 1 | 57 | edceusupvq(mmfjuzhdsv) = isalicxgly ddnhbmcrfo (ivkxhsblwj, -40.6, - 0.8) View more | - | 09 Jul 2020 | |||
dmmkodyjse(pajnokzwwd) = notviaeoik rozcrrjubc (agzimtsddn, 3, 46) | |||||||
Phase 3 | 321 | lwedhpuaqa(epuezccqgx) = wcmplebmtp zaedhumftf (tvecuzcjrt ) View more | Superior | 01 Jun 2020 | |||
lwedhpuaqa(epuezccqgx) = mtpxevviws zaedhumftf (tvecuzcjrt ) View more | |||||||
Not Applicable | - | dbjwiisczk(simnbrvulu) = taqgokgjff jjooqtxfur (vemrxztlvd ) | - | 01 Jun 2020 |